RWD Patients With Pulmonary Arterial Hypertension Treated With IP Prostacyclin Receptor Agonists
Condition(s):Pulmonary Arterial HypertensionLast Updated:November 7, 2022Recruiting
Hide Studies Not Open or Pending
Condition(s):Pulmonary Arterial HypertensionLast Updated:November 7, 2022Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:August 13, 2015Terminated
Condition(s):Pulmonary Arterial HypertensionLast Updated:June 2, 2020Completed
Condition(s):Pulmonary Arterial HypertensionLast Updated:November 22, 2021Unknown status
Condition(s):Pulmonary Arterial HypertensionLast Updated:February 27, 2014Unknown status
Condition(s):Pulmonary Arterial HypertensionLast Updated:April 18, 2023Not yet recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:March 15, 2024Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:October 10, 2023Active, not recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:December 15, 2023Recruiting
Condition(s):Pulmonary Arterial HypertensionLast Updated:June 9, 2022Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.